N-[2-(4-fluorophenyl)-5-propan-2-ylpyrimidin-4-yl]-3-[(2R)-2-methylpiperazin-1-yl]-1H-pyrrolo[2,3-b]pyridin-4-amine;N-[2-(4-fluorophenyl)-5-propan-2-ylpyrimidin-4-yl]-3-[(2S)-2-methylpiperazin-1-yl]-1H-pyrrolo[2,3-b]pyridin-4-amine;N-[2-(4-fluorophenyl)-5-propan-2-ylpyrimidin-4-yl]-3-morpholin-4-yl-1H-pyrrolo[2,3-b]pyridin-4-amine;N-[2-(4-fluorophenyl)-5-propan-2-ylpyrimidin-4-yl]-3-(1,2,4-triazol-1-yl)-1H-pyrrolo[2,3-b]pyridin-4-amine

C96H100F4N28O — CID 157178401

IUPACN-[2-(4-fluorophenyl)-5-propan-2-ylpyrimidin-4-yl]-3-[(2R)-2-methylpiperazin-1-yl]-1H-pyrrolo[2,3-b]pyridin-4-amine;N-[2-(4-fluorophenyl)-5-propan-2-ylpyrimidin-4-yl]-3-[(2S)-2-methylpiperazin-1-yl]-1H-pyrrolo[2,3-b]pyridin-4-amine;N-[2-(4-fluorophenyl)-5-propan-2-ylpyrimidin-4-yl]-3-morpholin-4-yl-1H-pyrrolo[2,3-b]pyridin-4-amine;N-[2-(4-fluorophenyl)-5-propan-2-ylpyrimidin-4-yl]-3-(1,2,4-triazol-1-yl)-1H-pyrrolo[2,3-b]pyridin-4-amine
SMILESCC(C)c1cnc(-c2ccc(F)cc2)nc1Nc1ccnc2[nH]cc(-n3cncn3)c12.CC(C)c1cnc(-c2ccc(F)cc2)nc1Nc1ccnc2[nH]cc(N3CCNC[C@@H]3C)c12.CC(C)c1cnc(-c2ccc(F)cc2)nc1Nc1ccnc2[nH]cc(N3CCNC[C@H]3C)c12.CC(C)c1cnc(-c2ccc(F)cc2)nc1Nc1ccnc2[nH]cc(N3CCOCC3)c12
InChIInChI=1S/2C25H28FN7.C24H25FN6O.C22H19FN8/c2*1-15(2)19-13-29-23(17-4-6-18(26)7-5-17)32-24(19)31-20-8-9-28-25-22(20)21(14-30-25)33-11-10-27-12-16(33)3;1-15(2)18-13-27-22(16-3-5-17(25)6-4-16)30-23(18)29-19-7-8-26-24-21(19)20(14-28-24)31-9-11-32-12-10-31;1-13(2)16-9-26-20(14-3-5-15(23)6-4-14)30-21(16)29-17-7-8-25-22-19(17)18(10-27-22)31-12-24-11-28-31/h2*4-9,13-16,27H,10-12H2,1-3H3,(H2,28,29,30,31,32);3-8,13-15H,9-12H2,1-2H3,(H2,26,27,28,29,30);3-13H,1-2H3,(H2,25,26,27,29,30)/t2*16-;;/m10../s1
InChIKeyAOHCTXUIFBHSHE-NNOCCYJRSA-N
MW1738.04 g/mol
LogP19.12
Rot. Bonds20

About N-[2-(4-fluorophenyl)-5-propan-2-ylpyrimidin-4-yl]-3-[(2R)-2-methylpiperazin-1-yl]-1H-pyrrolo[2,3-b]pyridin-4-amine;N-[2-(4-fluorophenyl)-5-propan-2-ylpyrimidin-4-yl]-3-[(2S)-2-methylpiperazin-1-yl]-1H-pyrrolo[2,3-b]pyridin-4-amine;N-[2-(4-fluorophenyl)-5-propan-2-ylpyrimidin-4-yl]-3-morpholin-4-yl-1H-pyrrolo[2,3-b]pyridin-4-amine;N-[2-(4-fluorophenyl)-5-propan-2-ylpyrimidin-4-yl]-3-(1,2,4-triazol-1-yl)-1H-pyrrolo[2,3-b]pyridin-4-amine

N-[2-(4-fluorophenyl)-5-propan-2-ylpyrimidin-4-yl]-3-[(2R)-2-methylpiperazin-1-yl]-1H-pyrrolo[2,3-b]pyridin-4-amine;N-[2-(4-fluorophenyl)-5-propan-2-ylpyrimidin-4-yl]-3-[(2S)-2-methylpiperazin-1-yl]-1H-pyrrolo[2,3-b]pyridin-4-amine;N-[2-(4-fluorophenyl)-5-propan-2-ylpyrimidin-4-yl]-3-morpholin-4-yl-1H-pyrrolo[2,3-b]pyridin-4-amine;N-[2-(4-fluorophenyl)-5-propan-2-ylpyrimidin-4-yl]-3-(1,2,4-triazol-1-yl)-1H-pyrrolo[2,3-b]pyridin-4-amine (PubChem CID 157178401) has the molecular formula C96H100F4N28O and a molecular weight of 1738.04 g/mol. Its IUPAC name is N-[2-(4-fluorophenyl)-5-propan-2-ylpyrimidin-4-yl]-3-[(2R)-2-methylpiperazin-1-yl]-1H-pyrrolo[2,3-b]pyridin-4-amine;N-[2-(4-fluorophenyl)-5-propan-2-ylpyrimidin-4-yl]-3-[(2S)-2-methylpiperazin-1-yl]-1H-pyrrolo[2,3-b]pyridin-4-amine;N-[2-(4-fluorophenyl)-5-propan-2-ylpyrimidin-4-yl]-3-morpholin-4-yl-1H-pyrrolo[2,3-b]pyridin-4-amine;N-[2-(4-fluorophenyl)-5-propan-2-ylpyrimidin-4-yl]-3-(1,2,4-triazol-1-yl)-1H-pyrrolo[2,3-b]pyridin-4-amine.

Molecular Properties

Compound NameN-[2-(4-fluorophenyl)-5-propan-2-ylpyrimidin-4-yl]-3-[(2R)-2-methylpiperazin-1-yl]-1H-pyrrolo[2,3-b]pyridin-4-amine;N-[2-(4-fluorophenyl)-5-propan-2-ylpyrimidin-4-yl]-3-[(2S)-2-methylpiperazin-1-yl]-1H-pyrrolo[2,3-b]pyridin-4-amine;N-[2-(4-fluorophenyl)-5-propan-2-ylpyrimidin-4-yl]-3-morpholin-4-yl-1H-pyrrolo[2,3-b]pyridin-4-amine;N-[2-(4-fluorophenyl)-5-propan-2-ylpyrimidin-4-yl]-3-(1,2,4-triazol-1-yl)-1H-pyrrolo[2,3-b]pyridin-4-amine
PubChem CID157178401
Molecular FormulaC96H100F4N28O
Molecular Weight1738.04 g/mol
Exact Mass1736.86
IUPAC NameN-[2-(4-fluorophenyl)-5-propan-2-ylpyrimidin-4-yl]-3-[(2R)-2-methylpiperazin-1-yl]-1H-pyrrolo[2,3-b]pyridin-4-amine;N-[2-(4-fluorophenyl)-5-propan-2-ylpyrimidin-4-yl]-3-[(2S)-2-methylpiperazin-1-yl]-1H-pyrrolo[2,3-b]pyridin-4-amine;N-[2-(4-fluorophenyl)-5-propan-2-ylpyrimidin-4-yl]-3-morpholin-4-yl-1H-pyrrolo[2,3-b]pyridin-4-amine;N-[2-(4-fluorophenyl)-5-propan-2-ylpyrimidin-4-yl]-3-(1,2,4-triazol-1-yl)-1H-pyrrolo[2,3-b]pyridin-4-amine
SMILESCC(C)c1cnc(-c2ccc(F)cc2)nc1Nc1ccnc2[nH]cc(-n3cncn3)c12.CC(C)c1cnc(-c2ccc(F)cc2)nc1Nc1ccnc2[nH]cc(N3CCNC[C@@H]3C)c12.CC(C)c1cnc(-c2ccc(F)cc2)nc1Nc1ccnc2[nH]cc(N3CCNC[C@H]3C)c12.CC(C)c1cnc(-c2ccc(F)cc2)nc1Nc1ccnc2[nH]cc(N3CCOCC3)c12
InChIInChI=1S/2C25H28FN7.C24H25FN6O.C22H19FN8/c2*1-15(2)19-13-29-23(17-4-6-18(26)7-5-17)32-24(19)31-20-8-9-28-25-22(20)21(14-30-25)33-11-10-27-12-16(33)3;1-15(2)18-13-27-22(16-3-5-17(25)6-4-16)30-23(18)29-19-7-8-26-24-21(19)20(14-28-24)31-9-11-32-12-10-31;1-13(2)16-9-26-20(14-3-5-15(23)6-4-14)30-21(16)29-17-7-8-25-22-19(17)18(10-27-22)31-12-24-11-28-31/h2*4-9,13-16,27H,10-12H2,1-3H3,(H2,28,29,30,31,32);3-8,13-15H,9-12H2,1-2H3,(H2,26,27,28,29,30);3-13H,1-2H3,(H2,25,26,27,29,30)/t2*16-;;/m10../s1
InChIKeyAOHCTXUIFBHSHE-NNOCCYJRSA-N
XLogP19.12
TPSA339.68 Ų
H-Bond Donors10
H-Bond Acceptors25
Rotatable Bonds20
Heavy Atoms129
Complexity

Lipinski Rule of Five

4 violations

RuleValue
MW ≤ 5001738.04
LogP ≤ 519.12
H-Bond Donors ≤ 510
H-Bond Acceptors ≤ 1025

Analyze N-[2-(4-fluorophenyl)-5-propan-2-ylpyrimidin-4-yl]-3-[(2R)-2-methylpiperazin-1-yl]-1H-pyrrolo[2,3-b]pyridin-4-amine;N-[2-(4-fluorophenyl)-5-propan-2-ylpyrimidin-4-yl]-3-[(2S)-2-methylpiperazin-1-yl]-1H-pyrrolo[2,3-b]pyridin-4-amine;N-[2-(4-fluorophenyl)-5-propan-2-ylpyrimidin-4-yl]-3-morpholin-4-yl-1H-pyrrolo[2,3-b]pyridin-4-amine;N-[2-(4-fluorophenyl)-5-propan-2-ylpyrimidin-4-yl]-3-(1,2,4-triazol-1-yl)-1H-pyrrolo[2,3-b]pyridin-4-amine with MolForge

Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.

Launch Full Analysis

Related Compounds

Frequently Asked Questions

What is the IUPAC name of N-[2-(4-fluorophenyl)-5-propan-2-ylpyrimidin-4-yl]-3-[(2R)-2-methylpiperazin-1-yl]-1H-pyrrolo[2,3-b]pyridin-4-amine;N-[2-(4-fluorophenyl)-5-propan-2-ylpyrimidin-4-yl]-3-[(2S)-2-methylpiperazin-1-yl]-1H-pyrrolo[2,3-b]pyridin-4-amine;N-[2-(4-fluorophenyl)-5-propan-2-ylpyrimidin-4-yl]-3-morpholin-4-yl-1H-pyrrolo[2,3-b]pyridin-4-amine;N-[2-(4-fluorophenyl)-5-propan-2-ylpyrimidin-4-yl]-3-(1,2,4-triazol-1-yl)-1H-pyrrolo[2,3-b]pyridin-4-amine?
The IUPAC name of N-[2-(4-fluorophenyl)-5-propan-2-ylpyrimidin-4-yl]-3-[(2R)-2-methylpiperazin-1-yl]-1H-pyrrolo[2,3-b]pyridin-4-amine;N-[2-(4-fluorophenyl)-5-propan-2-ylpyrimidin-4-yl]-3-[(2S)-2-methylpiperazin-1-yl]-1H-pyrrolo[2,3-b]pyridin-4-amine;N-[2-(4-fluorophenyl)-5-propan-2-ylpyrimidin-4-yl]-3-morpholin-4-yl-1H-pyrrolo[2,3-b]pyridin-4-amine;N-[2-(4-fluorophenyl)-5-propan-2-ylpyrimidin-4-yl]-3-(1,2,4-triazol-1-yl)-1H-pyrrolo[2,3-b]pyridin-4-amine (CID 157178401) is N-[2-(4-fluorophenyl)-5-propan-2-ylpyrimidin-4-yl]-3-[(2R)-2-methylpiperazin-1-yl]-1H-pyrrolo[2,3-b]pyridin-4-amine;N-[2-(4-fluorophenyl)-5-propan-2-ylpyrimidin-4-yl]-3-[(2S)-2-methylpiperazin-1-yl]-1H-pyrrolo[2,3-b]pyridin-4-amine;N-[2-(4-fluorophenyl)-5-propan-2-ylpyrimidin-4-yl]-3-morpholin-4-yl-1H-pyrrolo[2,3-b]pyridin-4-amine;N-[2-(4-fluorophenyl)-5-propan-2-ylpyrimidin-4-yl]-3-(1,2,4-triazol-1-yl)-1H-pyrrolo[2,3-b]pyridin-4-amine.
What is the SMILES notation for N-[2-(4-fluorophenyl)-5-propan-2-ylpyrimidin-4-yl]-3-[(2R)-2-methylpiperazin-1-yl]-1H-pyrrolo[2,3-b]pyridin-4-amine;N-[2-(4-fluorophenyl)-5-propan-2-ylpyrimidin-4-yl]-3-[(2S)-2-methylpiperazin-1-yl]-1H-pyrrolo[2,3-b]pyridin-4-amine;N-[2-(4-fluorophenyl)-5-propan-2-ylpyrimidin-4-yl]-3-morpholin-4-yl-1H-pyrrolo[2,3-b]pyridin-4-amine;N-[2-(4-fluorophenyl)-5-propan-2-ylpyrimidin-4-yl]-3-(1,2,4-triazol-1-yl)-1H-pyrrolo[2,3-b]pyridin-4-amine?
The canonical SMILES for N-[2-(4-fluorophenyl)-5-propan-2-ylpyrimidin-4-yl]-3-[(2R)-2-methylpiperazin-1-yl]-1H-pyrrolo[2,3-b]pyridin-4-amine;N-[2-(4-fluorophenyl)-5-propan-2-ylpyrimidin-4-yl]-3-[(2S)-2-methylpiperazin-1-yl]-1H-pyrrolo[2,3-b]pyridin-4-amine;N-[2-(4-fluorophenyl)-5-propan-2-ylpyrimidin-4-yl]-3-morpholin-4-yl-1H-pyrrolo[2,3-b]pyridin-4-amine;N-[2-(4-fluorophenyl)-5-propan-2-ylpyrimidin-4-yl]-3-(1,2,4-triazol-1-yl)-1H-pyrrolo[2,3-b]pyridin-4-amine is CC(C)c1cnc(-c2ccc(F)cc2)nc1Nc1ccnc2[nH]cc(-n3cncn3)c12.CC(C)c1cnc(-c2ccc(F)cc2)nc1Nc1ccnc2[nH]cc(N3CCNC[C@@H]3C)c12.CC(C)c1cnc(-c2ccc(F)cc2)nc1Nc1ccnc2[nH]cc(N3CCNC[C@H]3C)c12.CC(C)c1cnc(-c2ccc(F)cc2)nc1Nc1ccnc2[nH]cc(N3CCOCC3)c12.
What is the InChIKey of N-[2-(4-fluorophenyl)-5-propan-2-ylpyrimidin-4-yl]-3-[(2R)-2-methylpiperazin-1-yl]-1H-pyrrolo[2,3-b]pyridin-4-amine;N-[2-(4-fluorophenyl)-5-propan-2-ylpyrimidin-4-yl]-3-[(2S)-2-methylpiperazin-1-yl]-1H-pyrrolo[2,3-b]pyridin-4-amine;N-[2-(4-fluorophenyl)-5-propan-2-ylpyrimidin-4-yl]-3-morpholin-4-yl-1H-pyrrolo[2,3-b]pyridin-4-amine;N-[2-(4-fluorophenyl)-5-propan-2-ylpyrimidin-4-yl]-3-(1,2,4-triazol-1-yl)-1H-pyrrolo[2,3-b]pyridin-4-amine?
The InChIKey is AOHCTXUIFBHSHE-NNOCCYJRSA-N. The full InChI is InChI=1S/2C25H28FN7.C24H25FN6O.C22H19FN8/c2*1-15(2)19-13-29-23(17-4-6-18(26)7-5-17)32-24(19)31-20-8-9-28-25-22(20)21(14-30-25)33-11-10-27-12-16(33)3;1-15(2)18-13-27-22(16-3-5-17(25)6-4-16)30-23(18)29-19-7-8-26-24-21(19)20(14-28-24)31-9-11-32-12-10-31;1-13(2)16-9-26-20(14-3-5-15(23)6-4-14)30-21(16)29-17-7-8-25-22-19(17)18(10-27-22)31-12-24-11-28-31/h2*4-9,13-16,27H,10-12H2,1-3H3,(H2,28,29,30,31,32);3-8,13-15H,9-12H2,1-2H3,(H2,26,27,28,29,30);3-13H,1-2H3,(H2,25,26,27,29,30)/t2*16-;;/m10../s1.
What are the key properties of N-[2-(4-fluorophenyl)-5-propan-2-ylpyrimidin-4-yl]-3-[(2R)-2-methylpiperazin-1-yl]-1H-pyrrolo[2,3-b]pyridin-4-amine;N-[2-(4-fluorophenyl)-5-propan-2-ylpyrimidin-4-yl]-3-[(2S)-2-methylpiperazin-1-yl]-1H-pyrrolo[2,3-b]pyridin-4-amine;N-[2-(4-fluorophenyl)-5-propan-2-ylpyrimidin-4-yl]-3-morpholin-4-yl-1H-pyrrolo[2,3-b]pyridin-4-amine;N-[2-(4-fluorophenyl)-5-propan-2-ylpyrimidin-4-yl]-3-(1,2,4-triazol-1-yl)-1H-pyrrolo[2,3-b]pyridin-4-amine?
N-[2-(4-fluorophenyl)-5-propan-2-ylpyrimidin-4-yl]-3-[(2R)-2-methylpiperazin-1-yl]-1H-pyrrolo[2,3-b]pyridin-4-amine;N-[2-(4-fluorophenyl)-5-propan-2-ylpyrimidin-4-yl]-3-[(2S)-2-methylpiperazin-1-yl]-1H-pyrrolo[2,3-b]pyridin-4-amine;N-[2-(4-fluorophenyl)-5-propan-2-ylpyrimidin-4-yl]-3-morpholin-4-yl-1H-pyrrolo[2,3-b]pyridin-4-amine;N-[2-(4-fluorophenyl)-5-propan-2-ylpyrimidin-4-yl]-3-(1,2,4-triazol-1-yl)-1H-pyrrolo[2,3-b]pyridin-4-amine has a molecular weight of 1738.04 g/mol, XLogP of 19.12, 20 rotatable bonds, 10 hydrogen bond donors, and 25 hydrogen bond acceptors.
Where does this data come from?
All data for N-[2-(4-fluorophenyl)-5-propan-2-ylpyrimidin-4-yl]-3-[(2R)-2-methylpiperazin-1-yl]-1H-pyrrolo[2,3-b]pyridin-4-amine;N-[2-(4-fluorophenyl)-5-propan-2-ylpyrimidin-4-yl]-3-[(2S)-2-methylpiperazin-1-yl]-1H-pyrrolo[2,3-b]pyridin-4-amine;N-[2-(4-fluorophenyl)-5-propan-2-ylpyrimidin-4-yl]-3-morpholin-4-yl-1H-pyrrolo[2,3-b]pyridin-4-amine;N-[2-(4-fluorophenyl)-5-propan-2-ylpyrimidin-4-yl]-3-(1,2,4-triazol-1-yl)-1H-pyrrolo[2,3-b]pyridin-4-amine is sourced from PubChem (CID 157178401), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).